Richard Isnard

12.4k citations
171 papers · 9.6k · 6 hit papers · h-index 49

Impact in

Papers in

    • Heart Failure Treatment and Management 49
    • Cardiomyopathy and Myosin Studies 32
    • Cardiovascular Function and Risk Factors 18
    • Cardiac Valve Diseases and Treatments 7
    • Cardiac tumors and thrombi 6
    • Atrial Fibrillation Management and Outcomes 5

Richard Isnard

162 papers receiving 9.1k citations

Richard Isnard's Hit Papers

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial 2025 · 41 citations
410+7+15Years since publication2505007501k

Peers

Richard Isnard
Comparison fields: 5 of 140
  • Cardiology and Cardiovascular Medicine 5.8k
  • Critical Care and Intensive Care Medicine 170
  • Molecular Biology 1.7k
  • Internal Medicine 63
  • Genetics 481
Replace Yoshifusa Aizawa with:
Yoshifusa Aizawa Japan
Louis J. Dell’Italia United States
Brian D. Hoit United States
Yochai Birnbaum United States
Andreas Mügge Germany
Yasuchika Takeishi Japan
Toshihisa Anzai Japan
Lorenzo Malatino Italy
Antonino Tuttolomondo Italy
Ignatios Ikonomidis Greece
Richard Isnard relative to Yoshifusa Aizawa Japan Yoshifusa Aizawa's profile →
Citations per field
00.5×2×3×4×5×
Yoshifusa Aizawa · 1×
Citations per year

Countries citing papers authored by Richard Isnard

Since Specialization
Citations

This map shows the geographic impact of Richard Isnard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Isnard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Isnard more than expected).

Fields of papers citing papers by Richard Isnard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Isnard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Isnard. The network helps show where Richard Isnard may publish in the future.

Co-authors

The 25 scholars most cited alongside Richard Isnard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard Isnard Line = papers co-authored together Richard Isnard links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 171 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Hypertrophic Cardiomyopathy
Hit paper breakdown →
20031053
2
Atlas of the clinical genetics of human dilated cardiomyopathy
Hit paper breakdown →
2014464
3
Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
Hit paper breakdown →
2020367
4 2017301
5 2006288
6 2011283
7 2004279
8 1998221
9 2004205
10
Microbiome and metabolome features of the cardiometabolic disease spectrum
Hit paper breakdown →
2022205
11 1989201
12 1997197
13 2020195
14 1996191
15
Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial
Hit paper breakdown →
2022185
16 2011178
17 2017175
18 2021169
19 1993144
20 2020143

About Richard Isnard

Richard Isnard is a scholar working on Cardiology and Cardiovascular Medicine, Genetics, Cellular and Molecular Neuroscience, Pulmonary and Respiratory Medicine and Genetics, having authored 171 papers that have together received 9.6k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (49 papers), Cardiomyopathy and Myosin Studies (32 papers), Cardiovascular Function and Risk Factors (18 papers), Cardiac Valve Diseases and Treatments (7 papers), Gut microbiota and health (7 papers), Genetic Neurodegenerative Diseases (6 papers), Cardiac tumors and thrombi (6 papers) and Atrial Fibrillation Management and Outcomes (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (5.8k citations), Critical Care and Intensive Care Medicine (170 citations), Molecular Biology (1.7k citations), Internal Medicine (63 citations) and Genetics (481 citations). Richard Isnard has collaborated with scholars based in France, Germany and United Kingdom. Frequent co-authors include Michel Komajda N, Philippe Charron, Pascale Richard, Ketty Schwartz, Lucie Carrier, Olivier Dubourg, Michel Desnos, Bernard Hainque, Françoise Pousset and A Millaire. Their work appears in journals such as European Heart Journal, Archives of cardiovascular diseases, European Journal of Heart Failure, Circulation and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact